Boston University

The initiative's four research projects will use use genetic and other technologies to detect and treat cancer at its earliest stages.

Eleven new studies from the NHLBI NextGen Consortium show different uses for iPSCs to study polygenetic diseases across various systems in the human body.

This Week in Cell

In Cell this week: genomic events that could make attenuated polio virulent, formation of regulatory RNAs, and more.

The investigators will conduct a longitudinal study of former athletes with high and medium exposure to repetitive head trauma, including former NFL players.

Public health researchers argue in NEJM that precision medicine initiatives will take away from needed efforts to improve population health.

Aperiomics launched its commercial sequencing and bioinformatics-based pathogen detection service at the annual meeting of the Association for Molecular Pathology last week, with three offerings: Absolute-ID, Absolute-Discovery, and Absolute-Biome.

NEW YORK (GenomeWeb) — A US-Israeli team has developed an improved optical method for reading out the ion current through solid-state nanopores, providing an alternative to present approaches for nanopore sequencing that use electrical measurements.

Packaging isothermal PCR reagents in blisters and using lateral flow detection, researchers at Boston University hope to develop a low-cost, disposable assay for Bordetella pertussis, the causative agent of whooping cough.

NEW YORK (GenomeWeb News) – Two studies appearing in the American Journal of Human Genetics today uncovered a handful of low-frequency variants, including novel variants in ANGPTL8, PNPLA5, and PCSK7, among others, that seem to contribute to cholesterol or lipid levels in the blood.

NEW YORK (GenomeWeb News) – Boston University has proposed building a new research center that will house interdisciplinary life sciences research projects involving systems and synthetic biology and neuroscience.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.